Skip to content
Menu

NB Bancorp, Inc. NBBK

Full chart Compare
Set alert

Price alert · NBBK

All alert types
21.87 USD -0.04 (-0.18%)

Regular-session close

21.87 0.00 0.00%

After hours · Nov 13, 4:00 PM ET

21.78 Day range 22.37
18.11 52-week range 23.47
YTD
+10.34%
1 year
+14.98%

Fundamental scorecard

11 of 25 checks passed on NBBK’s reported financials

Value: 3/5ValueGrowth: 3/5GrowthProfitability: 3/5ProfitabilityFinancial health: n/aHealthDividend: 2/5Dividend

11of 25 checks passed

  • Value 3 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health No data
  • Dividend 2 of 5

Statements to Sep 30, 2026.

Value 3 of 5

  • Passed:P/E below its own 5-year median P/E 14.3 against a 5-year median of 18.3.
  • Passed:P/E under 20 P/E 14.3: an earnings yield of 7.0%.
  • Passed:Price to sales below its own 5-year median Price to sales 3.5 against a 5-year median of 3.8.
  • Failed:Price to book below its own 5-year median Price to book 1.1 against a 5-year median of 0.9.
  • No data:Free cash flow yield above 4% Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.

Growth 3 of 5

  • Passed:Revenue grew over the last year Revenue of 274M is +43.8% on the 12 months before.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Passed:Earnings per share grew over the last year EPS 1.67 against 1.55 in the 12 months before.
  • No data:Earnings per share grew more than 5% a year over five years Not enough data to decide.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +54.8% on the last 12 months.

Profitability 3 of 5

  • Passed:Profitable over the last year Net income of 66.9M over the last 12 months.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of 8.4%.
  • Passed:Net margin above its 5-year average Net margin of 24.4% against a 5-year average of 22.2%.
  • No data:Free cash flow is at least 80% of net income Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.

Financial health No data

  • No data:Short-term assets cover short-term liabilities The balance sheet does not split short-term from long-term (common for banks and insurers).
  • No data:Short-term assets cover long-term liabilities The balance sheet does not split short-term from long-term (common for banks and insurers).
  • No data:Net debt under 40% of equity Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.
  • No data:Operating cash flow covers at least 20% of debt Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.
  • No data:Operating profit covers interest at least 3 times Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.

Dividend 2 of 5

  • Passed:Pays a dividend 12.1M paid over the last 12 months.
  • Failed:Yield above 1.5% A yield of 1.3% at the current market value.
  • Passed:Pays out under 75% of profit 18.1% of net income is paid out.
  • No data:Covered by free cash flow Not measured for banks, insurers and similar lenders: their cash flows and debt mean something different.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

P/E against peers

Price over the last twelve months of earnings, NBBK and similar companies

NBBK trades at 14.3 times earnings, 27% below its peers' median of 19.6.

Peers’ median 19.6. A bar with a notched end runs past the scale. Peers are companies in a similar business; a P/E alone does not say whether a stock is cheap.

Financial position

What NBBK owns and owes, as of Sep 30, 2026

Balance sheet · 7.68B of assets

Debt, equity and cash by year

Now: 116M more cash than debt

  • Equity
  • Debt
  • Cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Cash flow and returns

How NBBK’s profit turns into cash, and what its capital earns

Returns on capital · Last 12 months

  • Benchmark 15%

    8.4%

    Return on equity

    Below the 15% mark · Profit per dollar of shareholders’ equity

  • Benchmark 5%

    1.0%

    Return on assets

    Below the 5% mark · Profit per dollar of everything it owns

From the company’s SEC filings. The tick on each dial is a common rule-of-thumb level, not a target.

Financial health

Altman Z-Score

-0.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B+3 / 5 overall

  • DCF 5
  • Return on Equity 2
  • Return on Assets 2
  • Debt / Equity 4
  • P/E 2
  • P/B 3

Valuation

P/E 14.8×
FY 2021: 27.0×FY 2022: 19.7×FY 2023: 58.5×FY 2024: 16.9×FY 2025: 14.8×
FY 2021 5y median 19.7× FY 2025
P/S 2.6×
FY 2021: 6.0×FY 2022: 4.6×FY 2023: 2.4×FY 2024: 2.3×FY 2025: 2.6×
FY 2021 5y median 2.6× FY 2025
P/B 0.9×
FY 2021: 1.8×FY 2022: 1.7×FY 2023: 0.7×FY 2024: 0.9×FY 2025: 0.9×
FY 2021 5y median 0.9× FY 2025
P/FCF 14.1×
FY 2021: 14.0×FY 2022: 18.8×FY 2023: 11.3×FY 2024: 17.2×FY 2025: 14.1×
FY 2021 5y median 14.1× FY 2025
EV/EBITDA 9.1×
FY 2021: 4.4×FY 2022: 19.3×FY 2023: 51.7×FY 2024: 10.1×FY 2025: 9.1×
FY 2021 5y median 10.1× FY 2025
EV/Sales 2.1×
FY 2021: 1.3×FY 2022: 5.8×FY 2023: 3.2×FY 2024: 2.0×FY 2025: 2.1×
FY 2021 5y median 2.1× FY 2025
FCF Yield 7.1%
FY 2021: 7.1%FY 2022: 5.3%FY 2023: 8.9%FY 2024: 5.8%FY 2025: 7.1%
FY 2021 5y median 7.1% FY 2025

Profitability

Gross Margin 54.9%
FY 2021: 85.1%FY 2022: 82.7%FY 2023: 56.1%FY 2024: 52.8%FY 2025: 54.9%
FY 2021 5y median 56.1% FY 2025
Operating Margin 22.4%
FY 2021: 28.0%FY 2022: 28.2%FY 2023: 5.0%FY 2024: 19.3%FY 2025: 22.4%
FY 2021 5y median 22.4% FY 2025
Net Margin 15.9%
FY 2021: 21.8%FY 2022: 23.3%FY 2023: 4.1%FY 2024: 13.9%FY 2025: 15.9%
FY 2021 5y median 15.9% FY 2025
ROE 5.9%
FY 2021: 6.6%FY 2022: 8.7%FY 2023: 1.3%FY 2024: 5.5%FY 2025: 5.9%
FY 2021 5y median 5.9% FY 2025
ROIC 0.7%
FY 2021: 6.5%FY 2022: 4.6%FY 2023: 0.9%FY 2024: 4.3%FY 2025: 0.7%
FY 2021 5y median 4.3% FY 2025
ROA 0.7%
FY 2021: 0.7%FY 2022: 0.8%FY 2023: 0.2%FY 2024: 0.8%FY 2025: 0.7%
FY 2021 5y median 0.7% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2021: 0.0%FY 2022: 30.5%FY 2023: 84.3%FY 2024: 28.0%FY 2025: 4.3%
FY 2021 FY 2025
Operating Income 21.3%
FY 2021: 0.0%FY 2022: 31.7%FY 2023: -67.5%FY 2024: 394.9%FY 2025: 21.3%
FY 2021 FY 2025
EPS (diluted) 25.2%
FY 2021: 0.0%FY 2022: 37.3%FY 2023: -67.1%FY 2024: 365.2%FY 2025: 25.2%
FY 2021 FY 2025
Free Cash Flow 39.1%
FY 2021: 0.0%FY 2022: -25.7%FY 2023: 60.3%FY 2024: -17.6%FY 2025: 39.1%
FY 2021 FY 2025

Financial Health

Current Ratio 307×
FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 307×
FY 2021 5y median 0.2× FY 2025
Quick Ratio 307×
FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 307×
FY 2021 5y median 0.2× FY 2025
Debt / Equity 0.2×
FY 2021: 0.0×FY 2022: 0.9×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.2×
FY 2021 5y median 0.2× FY 2025
Net Debt / EBITDA -1.7×
FY 2021: -15.4×FY 2022: 4.2×FY 2023: 13.1×FY 2024: -1.5×FY 2025: -1.7×
FY 2021 5y median -1.5× FY 2025
Interest Coverage 0.5×
FY 2021: 2.2×FY 2022: 2.3×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 0.5×
FY 2021 5y median 0.5× FY 2025

Dividends

Dividend Yield 0.7%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.7%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 11.1%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 11.1%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31